Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

ANP32B, or not to be, that is the question for influenza virus.

Baker SF, Mehle A.

Elife. 2019 Jun 10;8. pii: e48084. doi: 10.7554/eLife.48084.

2.

Differential Splicing of ANP32A in Birds Alters Its Ability to Stimulate RNA Synthesis by Restricted Influenza Polymerase.

Baker SF, Ledwith MP, Mehle A.

Cell Rep. 2018 Sep 4;24(10):2581-2588.e4. doi: 10.1016/j.celrep.2018.08.012.

3.

Influenza virus recruits host protein kinase C to control assembly and activity of its replication machinery.

Mondal A, Dawson AR, Potts GK, Freiberger EC, Baker SF, Moser LA, Bernard KA, Coon JJ, Mehle A.

Elife. 2017 Jul 31;6. pii: e26910. doi: 10.7554/eLife.26910.

4.

Mutations at highly conserved residues in influenza A(H1N1)pdm09 virus affect neuraminidase activity.

Romero-Beltran L, Baker SF, Puerto-Solís M, González-Losa R, Conde-Ferraez L, Alvarez-Sánchez LC, Martínez-Sobrido L, Ayora-Talavera G.

Virus Res. 2016 Oct 2;225:1-9. doi: 10.1016/j.virusres.2016.09.002. Epub 2016 Sep 3.

PMID:
27596738
5.

Replication-Competent Influenza A Viruses Expressing Reporter Genes.

Breen M, Nogales A, Baker SF, Martínez-Sobrido L.

Viruses. 2016 Jun 23;8(7). pii: E179. doi: 10.3390/v8070179. Review.

6.

Mutations Designed by Ensemble Defect to Misfold Conserved RNA Structures of Influenza A Segments 7 and 8 Affect Splicing and Attenuate Viral Replication in Cell Culture.

Jiang T, Nogales A, Baker SF, Martinez-Sobrido L, Turner DH.

PLoS One. 2016 Jun 7;11(6):e0156906. doi: 10.1371/journal.pone.0156906. eCollection 2016.

7.

Replication-Competent Influenza A and B Viruses Expressing a Fluorescent Dynamic Timer Protein for In Vitro and In Vivo Studies.

Breen M, Nogales A, Baker SF, Perez DR, Martínez-Sobrido L.

PLoS One. 2016 Jan 25;11(1):e0147723. doi: 10.1371/journal.pone.0147723. eCollection 2016.

8.

Development and applications of single-cycle infectious influenza A virus (sciIAV).

Nogales A, Baker SF, Domm W, Martínez-Sobrido L.

Virus Res. 2016 May 2;216:26-40. doi: 10.1016/j.virusres.2015.07.013. Epub 2015 Jul 26. Review.

9.
10.

Competitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA).

Baker SF, Nogales A, Santiago FW, Topham DJ, Martínez-Sobrido L.

Vaccine. 2015 Jul 9;33(30):3562-70. doi: 10.1016/j.vaccine.2015.05.049. Epub 2015 Jun 1.

11.

An improved method for estimating antibody titers in microneutralization assay using green fluorescent protein.

Yang H, Baker SF, González ME, Topham DJ, Martínez-Sobrido L, Zand M, Holden-Wiltse J, Wu H.

J Biopharm Stat. 2016;26(3):409-20. doi: 10.1080/10543406.2015.1052475. Epub 2015 May 26.

12.

High-Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine.

Halliley JL, Khurana S, Krammer F, Fitzgerald T, Coyle EM, Chung KY, Baker SF, Yang H, Martínez-Sobrido L, Treanor JJ, Subbarao K, Golding H, Topham DJ, Sangster MY.

J Infect Dis. 2015 Oct 15;212(8):1270-8. doi: 10.1093/infdis/jiv210. Epub 2015 Apr 2.

13.

Replication-competent influenza A viruses expressing a red fluorescent protein.

Nogales A, Baker SF, Martínez-Sobrido L.

Virology. 2015 Feb;476:206-216. doi: 10.1016/j.virol.2014.12.006. Epub 2014 Dec 30.

14.

Development of a mouse-adapted live attenuated influenza virus that permits in vivo analysis of enhancements to the safety of live attenuated influenza virus vaccine.

Cox A, Baker SF, Nogales A, Martínez-Sobrido L, Dewhurst S.

J Virol. 2015 Mar;89(6):3421-6. doi: 10.1128/JVI.02636-14. Epub 2014 Dec 31.

15.

The specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus: a new class of adjuvant?

Ramon S, Baker SF, Sahler JM, Kim N, Feldsott EA, Serhan CN, Martínez-Sobrido L, Topham DJ, Phipps RP.

J Immunol. 2014 Dec 15;193(12):6031-40. doi: 10.4049/jimmunol.1302795. Epub 2014 Nov 12.

16.

Induction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus.

Guo H, Baker SF, Martínez-Sobrido L, Topham DJ.

J Virol. 2014 Oct;88(20):12006-16. doi: 10.1128/JVI.01847-14. Epub 2014 Aug 6.

17.

Influenza A and B virus intertypic reassortment through compatible viral packaging signals.

Baker SF, Nogales A, Finch C, Tuffy KM, Domm W, Perez DR, Topham DJ, Martínez-Sobrido L.

J Virol. 2014 Sep;88(18):10778-91. doi: 10.1128/JVI.01440-14. Epub 2014 Jul 9.

18.

Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development.

Nogales A, Baker SF, Ortiz-Riaño E, Dewhurst S, Topham DJ, Martínez-Sobrido L.

J Virol. 2014 Sep;88(18):10525-40. doi: 10.1128/JVI.01565-14. Epub 2014 Jun 25.

19.

Use of bacteriophage particles displaying influenza virus hemagglutinin for the detection of hemagglutination-inhibition antibodies.

Domm W, Brewer M, Baker SF, Feng C, Martínez-Sobrido L, Treanor J, Dewhurst S.

J Virol Methods. 2014 Mar;197:47-50. doi: 10.1016/j.jviromet.2013.11.018. Epub 2013 Dec 6. Erratum in: J Virol Methods. 2014 Sep;206():156.

20.

Crystallographic fragment screening and structure-based optimization yields a new class of influenza endonuclease inhibitors.

Bauman JD, Patel D, Baker SF, Vijayan RS, Xiang A, Parhi AK, Martínez-Sobrido L, LaVoie EJ, Das K, Arnold E.

ACS Chem Biol. 2013 Nov 15;8(11):2501-8. doi: 10.1021/cb400400j. Epub 2013 Sep 13.

21.

Protection against lethal influenza with a viral mimic.

Baker SF, Guo H, Albrecht RA, García-Sastre A, Topham DJ, Martínez-Sobrido L.

J Virol. 2013 Aug;87(15):8591-605. doi: 10.1128/JVI.01081-13. Epub 2013 May 29.

22.

Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections.

Cottreau J, Baker SF, DuPont HL, Garey KW.

Expert Rev Anti Infect Ther. 2010 Jul;8(7):747-60. doi: 10.1586/eri.10.58.

PMID:
20586560
23.

Discovering oxysterols in plasma: a window on the metabolome.

Griffiths WJ, Hornshaw M, Woffendin G, Baker SF, Lockhart A, Heidelberger S, Gustafsson M, Sjövall J, Wang Y.

J Proteome Res. 2008 Aug;7(8):3602-12. doi: 10.1021/pr8001639. Epub 2008 Jul 8.

24.

The link between dyslexic traits, executive functioning, impulsivity and social self-esteem among an offender and non-offender sample.

Baker SF, Ireland JL.

Int J Law Psychiatry. 2007 Nov-Dec;30(6):492-503. Epub 2007 Oct 4.

PMID:
17919728
25.

Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.

Six DA, Barbayianni E, Loukas V, Constantinou-Kokotou V, Hadjipavlou-Litina D, Stephens D, Wong AC, Magrioti V, Moutevelis-Minakakis P, Baker SF, Dennis EA, Kokotos G.

J Med Chem. 2007 Aug 23;50(17):4222-35. Epub 2007 Aug 2.

PMID:
17672443
26.

Peptidase allergen Der p 1 initiates apoptosis of epithelial cells independently of tight junction proteolysis.

Baker SF, Yin Y, Runswick SK, Stewart GA, Thompson PJ, Garrod DR, Robinson C.

Mol Membr Biol. 2003 Jan-Mar;20(1):71-81.

PMID:
12745920
27.

PPAR gamma-dependent anti-inflammatory action of rosiglitazone in human monocytes: suppression of TNF alpha secretion is not mediated by PTEN regulation.

Hong G, Davis B, Khatoon N, Baker SF, Brown J.

Biochem Biophys Res Commun. 2003 Apr 11;303(3):782-7.

PMID:
12670479
28.
29.

Use of capnography in the delivery room for assessment of endotracheal tube placement.

Repetto JE, Donohue PA-C PK, Baker SF, Kelly L, Nogee LM.

J Perinatol. 2001 Jul-Aug;21(5):284-7.

30.

"Will our baby be normal?" Answering questions asked by parents of premature infants.

Donohue PK, Baker SF, Allen MC.

JAAPA. 2000 Aug;13(8):79-84, 88, 94. No abstract available.

PMID:
11521618
31.

Peptidase allergens, occludin and claudins. Do their interactions facilitate the development of hypersensitivity reactions at mucosal surfaces?

Robinson C, Baker SF, Garrod DR.

Clin Exp Allergy. 2001 Feb;31(2):186-92. Review. No abstract available.

PMID:
11251620
32.

Racial disparity in infant mortality. What does it mean? What can you do?

Donohue PK, Baker SF.

JAAPA. 1999 Apr;12(4):21-4, 27. No abstract available.

PMID:
10728079
33.

Skin care management practices for premature infants.

Baker SF, Smith BJ, Donohue PK, Gleason CA.

J Perinatol. 1999 Sep;19(6 Pt 1):426-31.

PMID:
10685272
34.
35.

Purification and properties of an active site mutant, H48Q, of human non-pancreatic secreted phospholipase A2.

Edwards SH, Baker SF, Wilton DC.

Biochem Soc Trans. 1998 Aug;26(3):S239. No abstract available.

PMID:
9765958
37.

The hydrolysis of biological membranes by secreted phospholipases A.

Baker SF, Wilton DC.

Biochem Soc Trans. 1997 Nov;25(4):S598. No abstract available.

PMID:
9450026
38.

Mapping the interfacial binding surface of human secretory group IIa phospholipase A2.

Snitko Y, Koduri RS, Han SK, Othman R, Baker SF, Molini BJ, Wilton DC, Gelb MH, Cho W.

Biochemistry. 1997 Nov 25;36(47):14325-33.

PMID:
9398150
39.

Bioconversion of leukotriene D4 by lung dipeptidase.

Campbell BJ, Baker SF, Shukla SD, Forrester LJ, Zahler WL.

Biochim Biophys Acta. 1990 Jan 16;1042(1):107-12.

PMID:
2153408
40.

The effect of tetracycline on human liver cells in culture.

Zuckerman AJ, Baker SF, Dunkley LJ.

Br J Exp Pathol. 1968 Feb;49(1):20-3. No abstract available.

Supplemental Content

Loading ...
Support Center